Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 72603-747

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 72603-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figue 1 (Venlafaxine 1 Figure)

A scatter plot chart showing fold changes with 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and ODV (a metabolite) across various special populations including hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60, and gender. The x-axis represents change relative to the reference value.*

FDA Label Image

90 Tablets (Venlafaxine 150mg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by NorthStar Rx LLC. The label indicates the package contains 90 oral extended-release capsules. The label includes dosing and storage information, NDC 72603-749-01, manufacturer details, and a barcode.*

FDA Label Image

Figure 2 (Venlafaxine 2 Figure)

A forest plot chart showing fold change and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax and AUC) with various interacting drugs, including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to a reference value, and data points indicate the impact of each interacting drug on venlafaxine levels.*

FDA Label Image

Figure 3 (Venlafaxine 3 Figure)

A scatter plot graph depicting fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of various analytes when co-administered with interacting drugs including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis shows change relative to the reference value, with data points and error bars for each analyte and parameter combination.*

FDA Label Image

90 Tablets (Venlafaxine 37 5 mg)

VENLAFAXINE HYDROCHLORIDE Extended-Release Capsules, USP 37.5 mg strength in a blue, white, and purple label. The label notes product is for prescription use only and contains 90 capsules. Manufactured by NorthStar Rx LLC, with packaging details including NDC 72603-747-01. Additional information includes storage instructions, child resistance, and manufacturing by Alembic Pharmaceuticals in India.*

FDA Label Image

90 Tablets (Venlafaxine 75 mg)

The labeling for Venlafaxine Hydrochloride Extended-Release Capsules, USP, 75 mg strength by NorthStar Rx LLC. The package contains 90 capsules. The label includes dosage form, strength, NDC (72603-748-01), manufacturer information, storage instructions, and a barcode. It specifies the product is a prescription drug and is child-resistant packaging.*

FDA Label Image

Venlafaxine-structure (Venlafaxine Str)

Chemical structure of venlafaxine hydrochloride, depicting the molecular arrangement of its atoms including characteristic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.